Drug intelligence / Profile preview

Muktagem

Development stage: Unknown
Lead developer: Vyas Pharmaceuticals
Administration: Oral

Overview

Muktagem is an over-the-counter Ayurvedic proprietary medicine developed and manufactured by Vyas Pharmaceuticals. Formulated as a tablet, it contains a traditional blend of herbal and mineral ingredients, including Shuddha Sonageru, Avipattikar Churna, Kapardika Bhasma, Shankha Bhasma, and Yashtimadhu. Muktagem is primarily indicated for the management of digestive and biliary disorders, including hyperacidity, indigestion, heartburn, peptic ulcers, and mouth ulcers. It also serves as a natural calcium supplement to support bone health and vitality. The formulation works holistically to balance digestive acids, soothe the gastrointestinal tract, and promote mucosal healing.

Brand names: Muktagem
Other names: Muktagem TabletVyas MuktagemVyas Muktagem Tablet

Beyond the preview

Go deeper on Muktagem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muktagem.

Explore the full profile